These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 34959049)

  • 1. Regional brain atrophy and cognitive decline depend on definition of subjective cognitive decline.
    Morrison C; Dadar M; Shafiee N; Villeneuve S; Louis Collins D;
    Neuroimage Clin; 2022; 33():102923. PubMed ID: 34959049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. White matter hyperintensity load varies depending on subjective cognitive decline criteria.
    Morrison C; Dadar M; Villeneuve S; Ducharme S; Collins DL
    Geroscience; 2023 Feb; 45(1):17-28. PubMed ID: 36401741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolving Evidence for the Value of Neuroimaging Methods and Biological Markers in Subjects Categorized with Subjective Cognitive Decline.
    Lista S; Molinuevo JL; Cavedo E; Rami L; Amouyel P; Teipel SJ; Garaci F; Toschi N; Habert MO; Blennow K; Zetterberg H; O'Bryant SE; Johnson L; Galluzzi S; Bokde AL; Broich K; Herholz K; Bakardjian H; Dubois B; Jessen F; Carrillo MC; Aisen PS; Hampel H
    J Alzheimers Dis; 2015 Sep; 48 Suppl 1():S171-91. PubMed ID: 26402088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Earlier Biomarkers for Alzheimer's Disease: A Multimodal Neuroimaging Study of Individuals with Subjective Cognitive Decline.
    Parker AF; Smart CM; Scarapicchia V; Gawryluk JR;
    J Alzheimers Dis; 2020; 77(3):1067-1076. PubMed ID: 32804127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural imaging outcomes in subjective cognitive decline: Community vs. clinical-based samples.
    Pini L; Wennberg AM
    Exp Gerontol; 2021 Mar; 145():111216. PubMed ID: 33340685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain atrophy and patch-based grading in individuals from the CIMA-Q study: a progressive continuum from subjective cognitive decline to AD.
    Marcotte C; Potvin O; Collins DL; Rheault S; Duchesne S
    Sci Rep; 2019 Sep; 9(1):13532. PubMed ID: 31537852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between composite scores of domain-specific cognitive functions and regional patterns of atrophy and functional connectivity in the Alzheimer's disease spectrum.
    Amaefule CO; Dyrba M; Wolfsgruber S; Polcher A; Schneider A; Fliessbach K; Spottke A; Meiberth D; Preis L; Peters O; Incesoy EI; Spruth EJ; Priller J; Altenstein S; Bartels C; Wiltfang J; Janowitz D; Bürger K; Laske C; Munk M; Rudolph J; Glanz W; Dobisch L; Haynes JD; Dechent P; Ertl-Wagner B; Scheffler K; Kilimann I; Düzel E; Metzger CD; Wagner M; Jessen F; Teipel SJ
    Neuroimage Clin; 2021; 29():102533. PubMed ID: 33360018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional hyperperfusion in older adults with objectively-defined subtle cognitive decline.
    Thomas KR; Osuna JR; Weigand AJ; Edmonds EC; Clark AL; Holmqvist S; Cota IH; Wierenga CE; Bondi MW; Bangen KJ;
    J Cereb Blood Flow Metab; 2021 May; 41(5):1001-1012. PubMed ID: 32615887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain MRI Biomarkers to Predict Cognitive Decline in Older People with Alzheimer's Disease.
    Zhu LY; Shi L; Luo Y; Leung J; Kwok T
    J Alzheimers Dis; 2022; 88(2):763-769. PubMed ID: 35723095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered mismatch response precedes gray matter atrophy in subjective cognitive decline.
    Cheng CH; Chang CC; Chao YP; Lu H; Peng SW; Wang PN
    Psychophysiology; 2021 Jun; 58(6):e13820. PubMed ID: 33792049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Automated Brain MRI Volumetry Differentiates Early Stages of Alzheimer's Disease From Normal Aging.
    Zhao W; Luo Y; Zhao L; Mok V; Su L; Yin C; Sun Y; Lu J; Shi L; Han Y
    J Geriatr Psychiatry Neurol; 2019 Nov; 32(6):354-364. PubMed ID: 31480984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-sectional and longitudinal characterization of SCD patients recruited from the community versus from a memory clinic: subjective cognitive decline, psychoaffective factors, cognitive performances, and atrophy progression over time.
    Kuhn E; Moulinet I; Perrotin A; La Joie R; Landeau B; Tomadesso C; Bejanin A; Sherif S; De La Sayette V; Desgranges B; Vivien D; Poisnel G; Chételat G
    Alzheimers Res Ther; 2019 Jul; 11(1):61. PubMed ID: 31286994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Influence of Amyloid Burden on Cognitive Decline over 2 years in Older Adults with Subjective Cognitive Decline: A Prospective Cohort Study.
    Hong YJ; Park JW; Lee SB; Kim SH; Kim Y; Ryu DW; Park KW; Yang DW
    Dement Geriatr Cogn Disord; 2021; 50(5):437-445. PubMed ID: 34736258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered Neuroanatomical Asymmetries of Subcortical Structures in Subjective Cognitive Decline, Amnestic Mild Cognitive Impairment, and Alzheimer's Disease.
    Fu Z; Zhao M; Wang X; He Y; Tian Y; Yang Y; Han Y; Li S
    J Alzheimers Dis; 2021; 79(3):1121-1132. PubMed ID: 33386805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal structural cerebral changes related to core CSF biomarkers in preclinical Alzheimer's disease: A study of two independent datasets.
    Falcon C; Tucholka A; Monté-Rubio GC; Cacciaglia R; Operto G; Rami L; Gispert JD; Molinuevo JL;
    Neuroimage Clin; 2018; 19():190-201. PubMed ID: 30023169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alzheimer's disease pattern of brain atrophy predicts cognitive decline in Parkinson's disease.
    Weintraub D; Dietz N; Duda JE; Wolk DA; Doshi J; Xie SX; Davatzikos C; Clark CM; Siderowf A
    Brain; 2012 Jan; 135(Pt 1):170-80. PubMed ID: 22108576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visual Performance and Cortical Atrophy in Vision-Related Brain Regions Differ Between Older Adults with (or at Risk for) Alzheimer's Disease.
    Rehan S; Giroud N; Al-Yawer F; Wittich W; Phillips N
    J Alzheimers Dis; 2021; 83(3):1125-1148. PubMed ID: 34397410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of Grey Matter Atrophy at Different Stages of Parkinson's and Alzheimer's Diseases and Relation to Cognition.
    Kunst J; Marecek R; Klobusiakova P; Balazova Z; Anderkova L; Nemcova-Elfmarkova N; Rektorova I
    Brain Topogr; 2019 Jan; 32(1):142-160. PubMed ID: 30206799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlating Cognitive Decline with White Matter Lesion and Brain Atrophy Magnetic Resonance Imaging Measurements in Alzheimer's Disease.
    Bilello M; Doshi J; Nabavizadeh SA; Toledo JB; Erus G; Xie SX; Trojanowski JQ; Han X; Davatzikos C
    J Alzheimers Dis; 2015; 48(4):987-94. PubMed ID: 26402108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low Cognitive Awareness, but Not Complaint, is a Good Marker of Preclinical Alzheimer's Disease.
    Cacciamani F; Tandetnik C; Gagliardi G; Bertin H; Habert MO; Hampel H; Boukadida L; Révillon M; Epelbaum S; Dubois B;
    J Alzheimers Dis; 2017; 59(2):753-762. PubMed ID: 28671134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.